United States · FDA National Drug Code directory
Lithium Carbonate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 64980-205_27551a16-0172-427a-882e-0d2a52a1342b
- Product NDC
- 64980-205
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Lithium Carbonate
- Labeler
- Rising Pharma Holdings, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160323
- Source listing expiry
- 20261231
Source-listed ingredients
- LITHIUM CARBONATE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (64980-205-01) · 64980-205-01
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (64980-205-03) · 64980-205-03
- 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (64980-205-05) · 64980-205-05
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (64980-205-09) · 64980-205-09
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →